Alabama Clinical Therapeutics North Tower Site Number : 8400024

Birmingham, Alabama 35205

0 studies enrolling now · 1 studies all time

What they study most

Influenza Immunization

Studies at this site

• Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age. — Completed